Biotech

All Articles

Analysts go into Avidity's DMD succeed, revealing distinctions in data

.Avidity Biosciences satisfied financiers along with phase 1/2 records in Duchenne muscle dystrophy ...

Actinogen's cortisol blocker fails stage 2 depression research

.Actinogen Medical's cortisol blocker has missed the primary endpoint of a stage 2 research study in...

Bivictrix makes a decision going exclusive only technique to take ADC into center

.Antibody-drug conjugates (ADCs) have gone to the center of many a billion-dollar biobuck licensing ...

TPG tops up funds to $580M for expenditures throughout lifestyle sciences

.Asset manager TPG, which has actually supported biotechs such as Sionna Therapies and Santa Ana Bio...

Merck ceases phase 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT system has suffered another problem. Months after shuttering a stage 3 most ...

After a challenging year, Exscientia folds up right into Recursion

.After a year determined through pipe cuts, the shift of its CEO as well as unemployments, Exscienti...

Cullinan, after $25M package, restore bispecific to Port

.Cullinan Therapeutics was made an impression on sufficient along with Port BioMed's bispecific invu...

A more detailed examine Tough Biotech's Strong 15

.In this particular week's incident of "The Best Pipe," our experts are actually diving into Strong ...

Lilly deals with stage 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering commemorating the commenda...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, firings and r...